TPIDarvo

TPIDarvo is a brand name for a medication containing the active ingredient tedizolid phosphate. It is an oxazolidinone antibiotic used for the treatment of certain bacterial infections. Specifically, TPIDarvo is indicated for acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It functions by inhibiting bacterial protein synthesis, thereby stopping bacterial growth. TPIDarvo can be administered orally or intravenously. The medication is typically prescribed for a course of 6 days. Common side effects associated with TPIDarvo include nausea, vomiting, diarrhea, headache, and dizziness. It is important to note that this medication should only be used under the guidance of a healthcare professional. TPIDarvo is manufactured by Merck & Co.